Abvion Bio

Pioneering innovative antibody therapeutics rooted in the natural immune response.

[Abvion Bio @AbvionBio]

🎉 We are delighted to announce that @Tamara_Sem has joined our core team as Head of Discovery Technologies!

[Abvion Bio @AbvionBio]

Keep an eye on the Mendel Lectures’ YouTube channel, where the lecture will be uploaded in the coming weeks. https://t.co/sbW8CcPn4F (2/2)

[Abvion Bio @AbvionBio]

“𝐖𝐡𝐚𝐭 𝐝𝐨 𝐰𝐞 𝐤𝐧𝐨𝐰 𝐚𝐛𝐨𝐮𝐭 (𝐲𝐨𝐮𝐫) 𝐚𝐧𝐭𝐢𝐛𝐨𝐝𝐢𝐞𝐬?”

Our CTO and co-founder, Prof Albert Heck, will be presenting a Mendel Lecture on this topic on Thursday, October 17th. The event will take place at the Augustinian Abbey in Brno, Czech Republic. 1/2

[Abvion Bio @AbvionBio]

Learn more about our approach to #AntibodyDiscovery at https://t.co/VzGtwaJN8P. 3/3

[Abvion Bio @AbvionBio]

Exciting news from @AbvionBio!

We are excited to announce the signing of an agreement with a major international biopharma company. 1/3

[Abvion Bio @AbvionBio]

Here, we aim to provide insights into the biological mechanisms of disease by understanding the patient’s natural antibody repertoires. We anticipate these insights will be invaluable in unravelling disease mechanisms and enabling the development of new #AntibodyTherapeutics. 2/3

[Abvion Bio @AbvionBio]

By working together, we can accelerate the process of building a next generation of #AntibodyTherapeutics for the patients who need them. Discover our approach at https://t.co/VzGtwaKkYn & stay connected by following @AbvionBio for more updates.

#Biotech #Innovation

4/4

[Abvion Bio @AbvionBio]

Unlocking the Future of Antibody Therapeutics through Collaboration 🤝

At @AbvionBio we understand that innovation thrives on strong partnerships.

1/4

[Abvion Bio @AbvionBio]

Our platform offers:
- direct access to antibodies in biobanked materials
- identification of the biologically most relevant antibodies
- Polyclonal antibody sequence discovery

3/4

[Abvion Bio @AbvionBio]

Read more about the scientific basis of our approach:
(1) https://t.co/BZJvmFMWmV
(2) https://t.co/m3dibQqNuR
(3) https://t.co/Ww3FujEEN9

Or visit https://t.co/VzGtwaJN8P to learn more about our mission.

#AntibodyTherapeutics #AntibodyDiscovery #Biotech #Startup

4/4

[Abvion Bio @AbvionBio]

𝗨𝗻𝗹𝗲𝗮𝘀𝗵𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗽𝗼𝘄𝗲𝗿 𝗼𝗳 𝗻𝗮𝘁𝘂𝗿𝗮𝗹 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝗶𝗲𝘀

@AbvionBio is addressing global health threats by using the strength and specificity of the natural immune response. 🔬

1/4

[Abvion Bio @AbvionBio]

Our platform for serological antibody discovery is built on peer-reviewed research by the @hecklab at @UniUtrecht. We use it to discover naturally evolved antibodies, forming the foundation of new therapies that redefine standards of care and inspire a healthier tomorrow.

3/4

[Abvion Bio @AbvionBio]

@UniUtrecht Maurits den Boer completed his PhD in the @hecklab contributing to various new insights into antibody-mediated immunity. He authored and contributed to multiple works on serological antibody profiling and sequencing, laying the groundwork for Abvion’s antibody discovery platform.

[Abvion Bio @AbvionBio]

Meet the founders of @AbvionBio 🚀

Abvion was founded by Maurits den Boer and Albert Heck (@hecklab), both experts in the analysis of human antibody repertoires.

Learn more about our company and mission here: https://t.co/WE6b6PHH4d

#AntibodyTherapeutics #Biotech #Startup

[Abvion Bio @AbvionBio]

Albert Heck leads a research group of over 65 scientists at @UniUtrecht, known for pioneering work in protein biology and the study of antibody repertoires using mass spectrometry. He was awarded the Spinoza award, Krebs Medal and Thomson Medal for his groundbreaking research.

[Abvion Bio @AbvionBio]

Abvion’s CEO Maurits is currently attending the Antibody Engineering & Therapeutics Europe conference in London. Tune in tomorrow at 10:20 a.m. (Wed 5th) to hear him talk about the work at the @hecklab that laid the foundation for Abvion.
#AntibodyTherapeutics #AntibodyDiscovery

[Abvion Bio @AbvionBio]

Introducing @AbvionBio, a cutting-edge antibody discovery company.

Our mission is to discover novel antibody therapeutics by harnessing the power of the natural immune response.

More: https://t.co/WE6b6PIeTL

#Startup #Biotech #AntibodyTherapeutics @UniUtrecht @UtrechtInc